Master
Content
Held virtually via Zoom: 11:30 a.m. - 12:15 p.m. (CST)
Zoom Link
Meeting ID: 387 923 767
Passcode: 831342
| Date | Speaker | Title/Presentation |
|---|---|---|
| Jan. 8, 2024 | Dr. Richard Dillon. Guy’s Hospital/King’s College, London | FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML View Presentation (BCM Login Required) |
| Dec. 4, 2023 | Claudia Haferlach, M.D., MLL-Munich Leukemia Laboratory | SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis View Presentation (BCM login required) |
| Nov. 20 , 2023 | Nathali Kaushansky, M.D., Weizmann Institute of Science | Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis Join via Zoom Telephone: (713) 798-9666 Meeting ID: 387 923 767 Password: 831342 |
| Nov. 6, 2023 | María Linares, Ph.D., Universidad Complutense de Madrid | Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myelogenous leukemia View Presentation (BCM login required) |
| Sept. 25, 2023 | Carsten Müller-Tidow, Professor of Medicine, M.D., Heidelberg University Hospital | Plasticity of AML phenotypes: mechanisms and differentiation routes View Presentation (BCM login required) |
| Sept. 11, 2023 | Rolf Marschalek, Ph.D., Goethe-University, Inst. Pharm Biology | Diagnosing MLL-r leukemia and behind: knowledge about the function(s) of MLL and its fusion protein View Presentation (BCM login required) |
| Aug. 21, 2023 | Alvin Makohon-Moore, Ph.D. Hackensack Meridian Health Center for Discovery and Innovation Georgetown Lombardi Comprehensive Cancer Center | Quantifying past, present, and future cancer evolution View Presentation (BCM login required) |
| Aug. 7, 2023 | Mariusz Z. Ratajczak, M.D., Ph.D. University of Louisville | Intracellular complement {complosome] is expressed in hematopoietic stem/progenitor cells (HSPCs) and regulates cell trafficking, metabolism and proliferation in an intracrine Nlrp3 inflammasome-dependent manner View Presentation (BCM login required) |
| July 10, 2023 | Eulàlia Genescà, Ph.D. Josep Carreras Leukaemia Research Institute (IJC) | Role of genomics in the stratification and management of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials View Presentation (BCM login required) |
| June 26, 2023 | Triona Ni Chonghaile, Ph.D., Associate Professor Royal College of Surgeons in Ireland | New insights into paths of venetoclax resistance View Presentation (BCM login required) |
| June 12, 2023 | Catherine Lai, M.D., MPH Physician Leader, Leukemia Clinical Research Unit University of Pennsylvania | TP53 in AML and MDS: The new (old) kind on the block View Presentation (BCM login required) |
| May 15, 2023 | Courtney Jones, Ph.D. Princess Margaret Cancer Center | Metabolic deregulated pathways to explain leukemogenesis and decreased BCL2 sensitivity in AML |
| May 1, 2023 | Omar Abdel- Wahab, M.D. Edward P. Evans Chair in MDS Chair, Molecular Pharmacology Program Sloan Kettering Institute | Understanding and Targeting Altered RNA Splicing in Leukemia View Presentation (BCM login required) |
| Dec. 14, 2022 | Hitoshi Takizawa, Ph.D. Vice-Director and Professor International Research Center for Medical Sciences, Kumamoto University | Microbial signals in hematopoietic regulation View Presentation (BCM login required) |
| Nov. 7, 2022 | Cyrus Khandanpour, M.D. Deputy Director and Professor, University of Lübeck and University Hospital of Schleswig-Holstein | New Therapeutic Approaches for Leukemia View Presentation (BCM login required) |
